These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18669518)

  • 21. Extended-spectrum beta-lactamase-producing Escherichia coli isolated in the Al-Amiri Hospital in 2003 and compared with isolates from the Farwania hospital outbreak in 1994-96 in Kuwait.
    Dashti AA; West PW
    J Chemother; 2007 Jun; 19(3):271-6. PubMed ID: 17594921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended spectrum â-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal.
    Poudyal S; Bhatta DR; Shakya G; Upadhyaya B; Dumre SP; Buda G; Kandel BP
    Nepal Med Coll J; 2011 Mar; 13(1):34-8. PubMed ID: 21991699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class 1 integrons contributes to antibiotic resistance among clinical isolates of Escherichia coli producing extended-spectrum beta-lactamases.
    Chen T; Feng Y; Yuan JL; Qi Y; Cao YX; Wu Y
    Indian J Med Microbiol; 2013; 31(4):385-9. PubMed ID: 24064647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.
    Kang CI; Cha MK; Kim SH; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2014 May; 43(5):456-9. PubMed ID: 24690213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.
    Spanu T; Sanguinetti M; Tumbarello M; D'Inzeo T; Fiori B; Posteraro B; Santangelo R; Cauda R; Fadda G
    J Clin Microbiol; 2006 Sep; 44(9):3257-62. PubMed ID: 16954257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS; Sung JY; Koo SH; Kwon GC; Shin SY; Park JW
    Korean J Lab Med; 2007 Oct; 27(5):344-50. PubMed ID: 18094599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of the extended-spectrum beta-lactamase and qnr genes in clinical isolates of Escherichia coli.
    Park Y; Kang HK; Bae IK; Kim J; Kim JS; Uh Y; Jeong SH; Lee K
    Korean J Lab Med; 2009 Jun; 29(3):218-23. PubMed ID: 19571619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of CTX-M-14 and TEM-52 extended-spectrum beta-lactamases in fecal Escherichia coli isolates of captive ostrich in Portugal.
    Carneiro C; Araújo C; Gonçalves A; Vinué L; Somalo S; Ruiz E; Uliyakina I; Rodrigues J; Igrejas G; Poeta P; Torres C
    Foodborne Pathog Dis; 2010 Aug; 7(8):991-4. PubMed ID: 20367084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.